Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether doxycycline (Periostat) at a
sub-antimicrobial dose will decrease reperfusion injury after coronary artery bypass grafting
(CABG) surgery with cardiopulmonary bypass (CPB).